Fig. 5From: Clinical characteristics of hyperprogressive disease in NSCLC after treatment with immune checkpoint inhibitor: a systematic review and meta-analysisForest plot of the association between the number of metastasis sites and hyperprogressive disease. OR, odd ratio; CI, confidence intervalBack to article page